GlassScriptPhysician profile
Nathan A Stanton
NPI 1265534069
$5,632.83
in general payments reported to CMS, 2019-2025
33 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,108 · 2022: $2,546 · 2023: $1,077 · 2024: $367 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.79 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,845.16 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $441.04 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $421.65 | 2021-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $361.35 | 2021-2022 | |
| Janssen Biotech, INC. | $282.10 | 2021-2023 | |
| Myovant Sciences INC. | $275.32 | 2021-2022 | |
| Pfizer INC. | $249.50 | 2022-2025 | |
| Abbvie INC. | $228.22 | 2021-2023 | |
| Teleflex LLC | $177.65 | 2021-2023 | Urolift |
| Progenics Pharmaceuticals, INC. | $158.05 | 2022-2025 | Pylarify |
| Medtronic, INC. | $150.26 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $131.95 | 2021-2025 | Provenge |
| Endo Pharmaceuticals INC. | $121.86 | 2021-2022 | |
| Olympus America INC. | $97.67 | 2023-2025 | Itind System |
| Coloplast Corp | $84.66 | 2021-2023 | Titan |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $79.20 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $65.24 | 2023 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $54.09 | 2025 | Gentlecath Glide |
| Urogen Pharma, INC. | $50.37 | 2021-2023 | Jelmyto |
| Ethicon US, LLC | $45.93 | 2021-2025 | Echelon Flex |
| Tolmar Pharmaceuticals, INC. | $36.53 | 2022 | |
| Intuitive Surgical, INC. | $34.16 | 2022 | |
| Convatec INC. | $33.75 | 2021 | |
| Ferring Pharmaceuticals INC. | $30.35 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $25.75 | 2021 | |
| Endo USA, INC. | $23.91 | 2024 | Xiaflex |
| Calyxo, INC. | $23.70 | 2025 | Cvac Aspiration System |
| Rochester Medical Corporation | $23.37 | 2021 | |
| Procept Biorobotics Corporation | $19.09 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $17.50 | 2022 | |
| Tolmar, INC. | $15.98 | 2025 | Jatenzo, Eligard |
| Kowa Pharmaceuticals America, INC. | $15.63 | 2022 | |
| Allergan, INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.